HOLX250516P47500
- 0.14
- 0.000.00%
Hologic Newsroom
Stephens Maintains Hologic(HOLX.US) With Buy Rating, Cuts Target Price to $70
Hologic to Webcast Presentations at Upcoming Investor Conferences
Hologic Analyst Ratings
Stephens Adjusts Hologic Price Target to $70 From $77, Maintains Overweight Rating
Express News | Hologic Inc : Stephens Cuts Target Price to $70 From $77
Hologic (NASDAQ:HOLX) Has Some Way To Go To Become A Multi-Bagger
Notable Healthcare Headlines for the Week: Viatris, Novavax and UnitedHealth in Focus
Hologic Insider Bought Shares Worth $300,760, According to a Recent SEC Filing
Hologic's (NASDAQ:HOLX) Solid Earnings Are Supported By Other Strong Factors
S&P 500's Five Most Overbought and Oversold Stocks
Unusual Options Activity: SN, GILD and Others Attract Market Bets, SN V/OI Ratio Reaches 253.5
New Analyst Forecast: $HOLX Given $65.0 Price Target
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Cuts Target Price to $65
Mizuho Securities Maintains Hologic(HOLX.US) With Buy Rating, Cuts Target Price to $65
Price Over Earnings Overview: Hologic
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating
Hologic's Financial Outlook: Hold Rating Amid Revenue Decline and Tariff Challenges
Hologic Second Quarter 2025 Earnings: EPS Misses Expectations
A Quick Look at Today's Ratings for Hologic(HOLX.US), With a Forecast Between $65 to $71
Top Gap Ups and Downs on Friday: AAPL, MSI, ING and More